 comparison intraven amrinon dobutamin congest heart failur due cardiomyopathi prospect random studi consecut patient refractori congest heart failur chf due cardiomyopathi hemodynam respons infus amrinon dobutamin drug pulmonari arteri wedg pressur right atrial pressur system vascular resist cardiac index amrinon decreas right atrial pressur dobutamin posit chronotrop effect dobutamin increas heart rate amrinon chang right atrial pulmonari arteri wedg pressur baroreceptor respons preload dobutamin increas stroke volum index amrinon percent patient amrinon dobutamin reduct equal pulmonari arteri wedg pressur cardiac index equal similar number patient dobutamin neg fluid balanc patient amrinon patient dobutamin hemodynam criteria patient micrograms/kg/min amrinon effect mainten dose dobutamin variabl import advers effect drug regimen amrinon dobutamin effect safe agent short-term parenter therapi patient dilat cardiomyopathi sever chf unrespons oral medic